Co-Diagnostics submits coronavirus RT-PCR test for European approval

By LabPulse.com staff writers

February 21, 2020 -- Co-Diagnostics has filed for the CE Mark for its Logix Smart COVID-19 coronavirus reverse transcription polymerase chain reaction (RT-PCR) test.

In a statement, the Salt Lake City-based company said it expects to make the test available this month. Co-Diagnostics was among the first IVD vendors to announce the development of a test for the coronavirus, now known as SARS-CoV-2, which causes the respiratory illness COVID-19.

The assay was developed with proprietary RT-PCR technology that detects RNA in the novel coronavirus in a way that minimizes false positives, according to the company.

CT imaging outperforms DNA testing for early diagnosis of COVID-19
Chest computed tomography (CT) scans demonstrated better sensitivity than DNA testing for detecting coronavirus disease (COVID-19) in high-risk individuals...
FDA ups its game in oversight of pharmacogenetic tests
The U.S. Food and Drug Administration (FDA) has announced a joint effort between its drug and device wings to oversee pharmacogenetic tests. The move...
Coronavirus toll surges after sanction of CT diagnosis
The number of new confirmed cases of coronavirus disease (COVID-19) in China hit roughly 15,000 within the past 24 hours alone, a major increase, according...
Co-Diagnostics raises $10.2M, sells coronavirus tests
Molecular diagnostics company Co-Diagnostics is set to raise $10.2 million in a common stock offering to institutional investors. The company plans...
Co-Diagnostics developing test for new coronavirus
Molecular diagnostics company Co-Diagnostics has completed design work for a test to screen for the new coronavirus behind an outbreak in China.

Copyright © 2020 LabPulse.com

Last Updated np 2/21/2020 2:09:09 PM



Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current